Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Trading Statement

11 Jan 2023 07:00

RNS Number : 3291M
Steppe Cement Limited
11 January 2023
 

11 January 2023

Steppe Cement Ltd

Preliminary Update for the Year ended 31 December 2022

Steppe Cement Limited ("Steppe Cement") recorded good revenue growth in 2022 with positive market conditions for the business. The focus has been on the domestic market where Steppe Cement's market share remains resilient.

Steppe Cement recorded revenue for the year ended 31 December 2022 of 40,023 million Tenge ("KZT"), which was 11% higher than the KZT 36,020 million recorded for the previous year. In 2022, cement sales volume was 1,670,174 tonnes, being slightly lower than the 1,688,544 tonnes achieved for the previous year. The average price (ex-VAT) for delivered cement was KZT 23,963 per tonne in 2022, representing a 12% increase on the KZT 21,332 per tonne achieved in 2021. The average ex-factory price in 2022 stood at KZT 20,970 per tonne compared to 18,134 in 2021, which represents USD 45 per tonne based on 2022's average exchange rate of USD/KZT 461 vs 426 in 2021. As we were limited by our production, we concentrated on the markets closer to our factory.

In 2022, the cement market consumption in Kazakhstan remained at 11.6 million tonnes.

Steppe Cement's local market share was 14.5% compared to 13.9% in 2021. Exports have been reduced to zero to optimize logistics and concentrate sales in more attractive domestic markets. Overall, Kazakhstan imported 0.7 million tonnes of cement (vs 0.8 million tonnes in 2021) and exported 1.1 million tonnes (vs 1.6 million tonnes in 2021).

Official inflation in Kazakhstan was 20.3% and will have a significant impact on production costs in 2023, but we continue our capex program to increase production capacity of clinker and higher grades of cement by the summer of 2023, as well as to reduce power and coal consumption.

There were extreme weather conditions in Kazakhstan and logistical difficulties in the railway network in November and December 2022. The board is working to try to minimise their impact in 2023.

The full results and audited accounts denominated in USD are expected to be published in May 2023.

Steppe Cement's AIM nominated adviser and broker is RFC Ambrian Limited.

Nominated Adviser contact: Stephen Allen or Andrew Thomson on +61 8 9480 2500.

Broker contact: Charlie Cryer at +44 20 3440 680

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFIFIFLAILLIV
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
27th May 20267:00 amRNSAnnual Financial Report
10th Apr 20267:00 amRNSTrading Update for the Quarter ended 31 March 2026
19th Jan 20268:03 amRNSInvestor Presentation via Investor Meet Company
15th Jan 20263:02 pmRNSReplacement - Trading Update
15th Jan 202610:45 amRNSTrading Update, Board Changes and Investment Plan
29th Dec 20257:00 amRNSCapital Repayment Payment Date
29th Dec 20257:00 amRNSCapital Repayment Payment Date
9th Dec 202510:30 amRNSCapital Repayment Record Date
5th Dec 20259:17 amRNSResult of EGM
14th Nov 20257:00 amRNSProposed Reduction & Repayment of Capital and EGM
17th Oct 20257:00 amRNSTrading Update for Q3 2025
15th Sep 20257:00 amRNSHalf-year Report
25th Jul 202511:07 amRNSResult of AGM
21st Jul 20251:34 pmRNSAGM – Submission of Shareholder Questions
7th Jul 20258:00 amRNSTrading Update
26th Jun 20257:55 amRNSNotice of AGM
26th Jun 20257:54 amRNSAnnual Financial Report
8th Apr 20258:29 amRNSTrading update for the quarter ended 31 March 2025
14th Jan 20257:00 amRNSYear End Trading Update
2nd Jan 202510:00 amRNSCapital Repayment Payment
12th Dec 20247:00 amRNSCapital Repayment Record Date
6th Dec 20248:39 amRNSResult of EGM
15th Nov 20247:00 amRNSProposed Reduction & Repayment of Capital and EGM
14th Oct 20247:00 amRNSTrading Update for Q3 2024
4th Oct 20249:15 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSHalf-year Report
6th Aug 20248:21 amRNSDirector's Dealing
2nd Aug 20249:44 amRNSDirector's Dealing
12th Jul 202410:08 amRNSResult of AGM and Market Update for H1 2024
4th Jul 20247:00 amRNSAGM - Submission of Shareholder Questions
19th Jun 20247:00 amRNSNotice of AGM
19th Jun 20247:00 amRNSAnnual Financial Report
23rd May 20247:00 amRNSCapital Repayment Record Date
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions
9th Jun 20237:00 amRNSAnnual Financial Report
9th Jun 20237:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.